Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Parkinson Disease and DRD2[original query] |
---|
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Archives of neurology 2001 Feb 58 (2): 209-13. Goetz C G, Burke P F, Leurgans S, Berry-Kravis E, Blasucci L M, Raman R, Zhou |
Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. Journal of clinical psychopharmacology 2006 Apr 26 (2): 192-7. Hedenmalm Karin, Güzey Cüneyt, Dahl Marja-Liisa, Yue Qun-Ying, Spigset Ol |
Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008 Sep 147B (6): 890-7. Al Hadithy Asmar F, Wilffert Bob, Stewart Roy E, Looman Nicole M, Bruggeman Richard, Brouwers Jacobus R, Matroos Glenn E, van Os Jim, Hoek Hans W, van Harten Peter |
Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients. European journal of clinical pharmacology 2009 Jul 65 (7): 679-83. Liu Ying-Zi, Tang Bei-Sha, Yan Xin-Xiang, Liu Jie, Ouyang Dong-Sheng, Nie Li-Nuo, Fan Lan, Li Zhi, Ji Wei, Hu Dong-Li, Wang Dan, Zhou Hong-H |
Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorphisms. Scandinavian journal of psychology 2014 Jun 55 (3): 278-86. Ziegler David A, Ashourian Paymon, Wonderlick Julien S, Sarokhan Alison K, Prelec Drazen, Scherzer Clemens R, Corkin Suzan |
Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms. Parkinsonism & related disorders 2015 Nov . Hassan Anhar, Heckman Michael G, Ahlskog J E, Wszolek Zbigniew K, Serie Daniel J, Uitti Ryan J, van Gerpen Jay A, Okun Michael S, Rayaprolu Sruti, Ross Owen |
Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease. Brain and behavior 2018 Jun e01008. McDonell Katherine E, van Wouwe Nelleke C, Harrison Madaline B, Wylie Scott A, Claassen Daniel |
Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis. Medicine 2019 Sep 98 (37): e17136. Yu Ming, Huang Feiran, Wang Wei, Zhao Ch |
Association between dopamine receptor D2 TaqIA polymorphism and Parkinson disease risk: a meta-analysis. International journal of clinical and experimental pathology 2019 12 (9): 3165-3170. Song Yang, Wang Zhi-Yun, Jin Yan-Yu, Guo J |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: